312
Participants
Start Date
May 31, 2019
Primary Completion Date
November 13, 2019
Study Completion Date
January 15, 2020
CT-P17
40 mg/0.4ml (100 mg/mL) administered as a single SC injection via PFS
US-licensed Humira
40 mg/0.4ml (100 mg/mL) administered as a single SC injection via PFS
EU-approved Humira
40 mg/0.4ml (100 mg/mL) administered as a single SC injection via PFS
CHA Bundang Medical Center, Seongnam-si
Seoul National University Bundang Hospital, Seongnam-si
Chungbuk National University Hospital, Cheongju-si
Chungnam National University Hospital, Daejeon
Inje University Busan Paik Hospital, Busan
Chonbuk National University Hospital, Jeonju
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Asan Medical Center, Seoul
Lead Sponsor
Celltrion
INDUSTRY